发明授权
- 专利标题: Diaminopyrimidines as P2X3 and P2X2/3 antagonists
- 专利标题(中): 二氨基嘧啶作为P2X3和P2X2 / 3拮抗剂
-
申请号: US12963413申请日: 2010-12-08
-
公开(公告)号: US08846705B2公开(公告)日: 2014-09-30
- 发明人: Chris Allen Broka , David Scott Carter , Michael Patrick Dillon , Ronald Charles Hawley , Alam Jahangir , Clara Jeou Jen Lin , Daniel Warren Parish
- 申请人: Chris Allen Broka , David Scott Carter , Michael Patrick Dillon , Ronald Charles Hawley , Alam Jahangir , Clara Jeou Jen Lin , Daniel Warren Parish
- 申请人地址: US CA Palo Alto
- 专利权人: Roche Palo Alto LLC
- 当前专利权人: Roche Palo Alto LLC
- 当前专利权人地址: US CA Palo Alto
- 代理商 Robert C. Hall
- 主分类号: A61K31/505
- IPC分类号: A61K31/505 ; A61K31/506 ; C07D239/48 ; C07D403/12
摘要:
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein D, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
公开/授权文献
- US20110077242A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS 公开/授权日:2011-03-31
信息查询